<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Glomerular filtration rate and decline in renal function can be improved by global cardiovascular prevention </plain></SENT>
<SENT sid="1" pm="."><plain>However, the prevalence of <z:e sem="disease" ids="C0948347" disease_type="Disease or Syndrome" abbrv="">nephroangiosclerosis</z:e> in patients with <z:hpo ids='HP_0001297'>stroke</z:hpo> is unknown </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Using an autopsy data bank, we studied the prevalence of <z:e sem="disease" ids="C0948347" disease_type="Disease or Syndrome" abbrv="">nephroangiosclerosis</z:e> in 820 consecutive autopsies of neurologic patients </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Among the 820 autopsies, 354 had pathologic evidence of <z:hpo ids='HP_0001297'>stroke</z:hpo> and 466 had other <z:e sem="disease" ids="C1456669" disease_type="Disease or Syndrome" abbrv="">neurologic diseases</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0948347" disease_type="Disease or Syndrome" abbrv="">Nephroangiosclerosis</z:e> was found in 39.8% (95% confidence interval [CI], 34.7-44.9) of patients with <z:hpo ids='HP_0001297'>stroke</z:hpo> vs 9.0% (95% CI, 6.4-11.6) in patients with other <z:e sem="disease" ids="C1456669" disease_type="Disease or Syndrome" abbrv="">neurologic diseases</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The odds ratio (OR) for <z:e sem="disease" ids="C0948347" disease_type="Disease or Syndrome" abbrv="">nephroangiosclerosis</z:e>, adjusted for age and sex, was 4.37 (95% CI, 2.92-6.52), and was 2.94 (95% CI, 1.83-4.74) after further adjustment for <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Among the 354 <z:hpo ids='HP_0001297'>stroke</z:hpo> patients, the prevalence of <z:e sem="disease" ids="C0948347" disease_type="Disease or Syndrome" abbrv="">nephroangiosclerosis</z:e> was similar in patients with <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> and in those with brain <z:mp ids='MP_0001914'>hemorrhage</z:mp>, in patients with or without parenchymal abnormalities related to small-vessel disease, and across <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> subtypes except for those with coexisting causes </plain></SENT>
<SENT sid="7" pm="."><plain>After multivariable analysis, <z:e sem="disease" ids="C0948347" disease_type="Disease or Syndrome" abbrv="">nephroangiosclerosis</z:e> was independently associated with age and history of <z:hpo ids='HP_0000822'>hypertension</z:hpo> in patients with <z:hpo ids='HP_0001297'>stroke</z:hpo>, and with age in those with other <z:e sem="disease" ids="C1456669" disease_type="Disease or Syndrome" abbrv="">neurologic diseases</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="C0948347" disease_type="Disease or Syndrome" abbrv="">Nephroangiosclerosis</z:e> is common in patients with fatal <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>The association is independent of age, sex, and other <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000082'>Impaired renal function</z:hpo> should be monitored and prevented in <z:hpo ids='HP_0001297'>stroke</z:hpo> patients with <z:mp ids='MP_0002842'>high blood pressure</z:mp> </plain></SENT>
</text></document>